Abstract
Objective
Studies suggest that dying at home is a more favorable experience. This study investigated where amyotrophic lateral sclerosis (ALS) patients die and the patient demographics associated with dying in an acute care facility or nursing home compared to home or hospice.
Methods
Centers for Disease Control and Prevention Multiple Cause Mortality Files from 2005–2010 were used to identify ALS patients and to classify place of death. Multinomial logistic regression was used to determine the association between patient demographics and place of death.
Results
Between 2005 and 2010, 40,911 patients died of ALS in the United States. Place of death was as follows: home or hospice facility 20,231 (50%), acute care facility (25%), and nursing home (20%). African Americans (adjusted multinomial odds ratio (aMOR) 2.56, CI 2.32–2.83), Hispanics (aMOR 1.44, CI 1.30–1.62), and Asians (aMOR 1.87, CI 1.57–2.22) were more likely to die in an acute care facility, whereas females (aMOR 0.76, CI 0.72–0.80) and married individuals were less likely. Hispanics (aMOR 0.68, CI 0.58–0.79) and married individuals were less likely to die in a nursing home.
Conclusions
Minorities, men, and unmarried individuals are more likely to die in an acute care facility. Further studies are needed to better understand place of death preferences.
Keywords: End of life care, Amyotrophic lateral sclerosis, Quality of life, Place of death
Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of the motor neurons. As the typical survival is 2–5 years, end-of-life planning is an important component of routine care(1) and should aid patients in achieving a “good death” by addressing factors such as pain and symptom management, quality communication with physicians, and preparation for death(2).
Location of death is proposed as a quality measure for end of life care for all diseases(3). Death at home is associated with an improved quality of life near the end of life, less caregiver strain(4), and is generally viewed as a more satisfying and favorable experience per caregiver report(4, 5). Although death at home is not always considered as important as other factors in the process of dying(2), it does appear to be the desired location of death in many studies, but this request may not be met in all circumstances(3, 6). Furthermore, patients dying in a hospital or nursing home have unmet needs compared to patients who die at home with hospice care(5), and in cases of terminal cancer, quality of end-of-life care is inferior for those who die in a hospital compared to those who die at home with hospice care(4). In contrast, patients who die in hospice care have the fewest unmet needs(7).
In ALS, place of death is an important consideration because “not dying at home” is correlated with “not dying peacefully”(8). The purpose of this study is to investigate the current proportion of ALS patients who die at home and/or in hospice versus an acute care facility (ACF) or nursing home (NH) in the United States. Furthermore, we sought to evaluate the association between patient demographics and dying in an acute care facility or nursing home compared to home and/or hospice to inform future intervention efforts aimed at improving end of life care for ALS patients.
Methods
The Centers for Disease Control and Prevention (CDC) Multiple Cause Mortality Files for the years 2005–2010 were evaluated to determine an ALS death defined as a death certificate with ALS (ICD-10 G122) as the underlying cause of death. This dataset reports details of every death with in the United States in a given year as reported on death certificates. Place of death was abstracted from the death certificate and divided into four categories: home and/or hospice, acute care facility, nursing home, or other. Acute care facility deaths were defined as deaths occurring during acute inpatient hospitalization, at an outpatient medical facility, in an emergency department, or in patients who were dead on arrival to the hospital. Patient characteristics including age, sex, race/ethnicity, educational status, and marital status, were collected from the death certificates. Multinomial logistic regression was used to determine the association between independent variables (all patient characteristics included in the model) and the dependent variable (death in an acute care facility or nursing home versus home and/or hospice). Statistical analysis was performed with STATA version 12.1 (StataCorp College Station, TX). The study was Institutional Review Borad exempt.
Results
Between 2005 and 2010 40,911 patients died of ALS in the United States. Patient demographics are shown in Table 1. Mean age at time of death was 68.7 (SD 12.2) and 45.5% were female. Of the total population, 92.6% were white, 5.5% African American, 4.2% Hispanic, and 1.59% Asian. The most common location of death was home/hospice (49.7%), followed by an acute care facility (25.0%), nursing home (19.6%), and other (5.7%) (Table 2). Multinomial logistic regression revealed that females have a lower odds of dying in an acute care facility (adjusted multinomial odds ratio (aMOR) 0.76, CI 0.72–0.80) compared to males (Table 3). African Americans have an increased odds of dying in an acute care facility (aMOR 2.56, CI 2.32–2.83) but are equally likely to die in a nursing home (aMOR 1.09, CI 0.96–1.25). Hispanics have an increased odds of dying in an acute care facility (aMOR 1.44, CI 1.30–1.62) but a decreased odds of dying in a nursing home (aMOR 0.68, CI 0.58–0.79) compared to Whites. Asians have an increased odds of dying in an acute care facility (aMOR 1.87, CI 1.57–2.22) and a lower odds of dying in a nursing home, although this is not statistically significant (aMOR 0.80, CI 0.62–1.03). Single patients (ACF: aMOR 1.69, CI 1.52–1.89, NH: aMOR 4.30, CI 3.83–4.83), divorced patients (ACF: aMOR 1.51, CI 1.40–1.63, NH: aMOR 3.35, CI 3.09–3.64), and widowed patients (ACF: aMOR 1.26, CI 1.17–1.35, NH: aMOR, CI 2.16–2.50) all have an increased odds of dying in an acute care facility and in a nursing home compared to married patients. Age is significantly associated with an acute care death (aMOR 1.003, CI 1.001–1.005) and a nursing home death (aMOR 1.04, CI 1.04–1.05).
Table 1.
Patient Demographics
| Home or Hospice Facility Death |
Acute Care Death |
Nursing Home Death |
Other | Total | |
|---|---|---|---|---|---|
| (n = 20,321) | (n = 10,244) | (n = 8,009) | (n = 2,337) | (n = 40,911) | |
| N(%) unless otherwise specified |
N(%) unless otherwise specified |
N(%) unless otherwise specified |
N(%) unless otherwise specified |
N(%) unless otherwise specified |
|
| Mean Age (SD) in Years | 67.5 (11.9) | 67.3 (12.4) | 73.1 (11.5) | 69.4 (12.5) | 68.7 (12.2) |
| Female | 9,131 (44.9%) | 4,080 (39.8%) | 4,193 (52.4%) | 1,220 (52.2%) | 18,624 (45.5%) |
| Race/Ethnicity | |||||
| White | 19,174 (94.4%) | 8,972 (87.6%) | 7,557 (94.4%) | 2,185 (93.5%) | 37,888 (92.6%) |
| African American | 791 (3.9%) | 980 (9.6%) | 346 (4.3%) | 116 (5.0%) | 2,233 (5.5%) |
| Hispanic Ethnicity | 864 (4.3%) | 598 (5.8%) | 223 (2.8%) | 49 (2.1%) | 1,734 (4.2%) |
| Asian | 300 (1.5%) | 247 (2.4%) | 82 (1.0%) | 23 (1.0%) | 652 (1.59%) |
| Other | 56 (0.3%) | 45 (0.4%) | 24 (0.3%) | 13 (0.6%) | 138 (0.34%) |
| Marital Status | |||||
| Unknown | 21 (0.1%) | 28 (0.3%) | 12 (0.1%) | 283 (12.1%) | 344 (0.8%) |
| Single | 823 (4.0%) | 674 (6.6%) | 620 (7.7%) | 131 (5.6%) | 2,248 (5.5%) |
| Married | 14,663 (72.2%) | 6,665 (65.1%) | 3,632 (45.3%) | 1,092 (46.7%) | 26,052 (63.7%) |
| Divorced | 1,921 (9.5%) | 1,311 (12.8%) | 1,330 (16.6%) | 324 (13.9%) | 4,886 (11.9%) |
| Widowed | 2,893 (14.2%) | 1,566 (15.3%) | 2,415 (30.2%) | 507 (21.7%) | 7,381 (18.0%) |
Table 2.
ALS Deaths per Year Per Place of Death
| Location (% per year) |
2005 | 2006 | 2007 | 2008 | 2009 | 2010 | Total |
|---|---|---|---|---|---|---|---|
| Acute Care | 1,739 (27%) | 1,656 (25%) | 1,716 (26%) | 1,698 (25%) | 1,709 (24%) | 1,726 (24%) | 10,244 |
| Home or Hospice | 3,018 (46%) | 3,210 (49%) | 3,350 (50%) | 3,455 (50%) | 3,449 (49%) | 3,839 (49%) | 20,321 |
| Nursing Home | 1,406 (22%) | 1,401 (21%) | 1,308 (19%) | 1,293 (19%) | 1,307 (19%) | 1,294 (19%) | 8,009 |
| Other | 337 (5%) | 312 (5%) | 344 (5%) | 436 (6%) | 539 (8%) | 369 (8%) | 2,337 |
| Total ALS Deaths | 6,500 | 6,579 | 6,718 | 6,882 | 7,004 | 7,228 | 40,911 |
Table 3.
Logistic Regression of Death in an Acute Care Facility for ALS Patients
| Odds of dying in ACF vs Home/Hospice |
Odds of dying in Nursing Home vs Home/Hospice |
|||
|---|---|---|---|---|
| Parameter | Adjusted multinomial odds ratio |
95% CI | Adjusted multinomial odds ratio |
95% CI |
| Age (year) | 1.00* | 1.00–1.01 | 1.04* | 1.04–1.05 |
| Female | 0.76* | 0.72–0.80 | 0.98 | 0.92–1.03 |
| Race/Ethnicity (reference: white) | ||||
| African American | 2.56* | 2.32–2.83 | 1.09 | 0.96–1.25 |
| Hispanic | 1.44* | 1.30–1.62 | 0.68* | 0.58–0.79 |
| Asian | 1.87* | 1.57–2.22 | 0.80 | 0.62–1.03 |
| Other | 1.69* | 1.13–2.51 | 1.24 | 0.76–2.03 |
| Marital Status (reference: married) | ||||
| Unknown | 2.66* | 1.51–4.71 | 2.76 | 1.36–5.63 |
| Single | 1.69* | 1.52–1.89 | 4.30* | 3.83–4.83 |
| Divorced | 1.51* | 1.40–1.63 | 3.35* | 3.09–3.64 |
| Widowed | 1.26* | 1.17–1.35 | 2.32* | 2.16–2.50 |
= significant
Discussion
In the United States between 2005 and 2010, over 40,000 people died of ALS, of which 25% died in an acute care facility, 50% at home or in hospice, and 20% in a nursing home. Although there has been an increasing emphasis on dying at home and/or with hospice, our data suggests that almost half of recent ALS patient deaths continue to occur in other locations. Racial/ethnic minorities, men, and unmarried individuals were more likely to die in an acute care facility. Hispanics were less likely to die in a nursing home, whereas unmarried individuals were more likely.
African Americans and Hispanics, are more likely to die in an acute care facility relative to whites. Although this may represent preferences such as the aggressiveness of care at end-of-life in these groups(3), this could be related to other factors including lack of access or affordability of home care services or availability of informal caregivers which prevent patients from staying at home at the end-of-life. Our data are consistent with other studies investigating all causes of death that highlight different preferences and practices at end-of-life in African-Americans and other minority groups(2, 3, 9). These results suggest an opportunity may exist to enhance end of life care for ALS minority patients. We also found that Hispanics are less likely to die in a nursing home, which is consistent with previous work and also highlights the importance of separately evaluating nursing home deaths(3). Similar to Hispanics, Asians are more likely to die in an acute care facility and appear less likely to die in a nursing home. The interpretation of this data is uncertain as this category does not differentiate amongst different Asian heritages. In addition, other similar studies do not explicitly evaluate Asians as an individual racial/ethnic group, and therefore future studies are needed to understand end of life preferences in this group.
The finding that men are more likely to die in an ACF compared to women is consistent with studies that revealed similar associations when considering all causes of death(3, 5). However, our study is the first to evaluate this association in an ALS cohort. This observation could be the result of many factors including a difference in end-of-life wishes, the availability of informal caretakers to maintain the patient in a home or hospice setting, or a different disease course. Similar to minorities, this result may indicate an opportunity to improve the end of life experience for men, but further studies are needed to determine the reasons men are more likely to die in acute care facilities.
That unmarried individuals are more likely to die in an acute care facility and more likely to die in a nursing home is not surprising given the degree of disability associated with ALS, often resulting in loss of independence. The availability of a spouse to assist with activities of daily living likely allows these patients to stay in a home or hospice setting. Other studies have shown similar findings by demonstrating a relationship between marriage and home death(3, 10).
One limitation is that we do not have information on the patient’s preferred place of death. In addition, by relying on death certificate data, we cannot control for other potential factors that may have influenced place of death such as disease severity, other medical comorbidities, or acute illness. More insight on these limitations is required prior to making public health decisions. Strengths of this study include the comprehensive capture of a large nationwide sample of patients with a gold-standard definition of cause of death and separate evaluation of nursing home as a place of death.
According to the 2010 US Census, the national population by race was 74.2% white, 12.6% African American, 4.8% Asian, and 16.3% Hispanic or Latino(11). The racial makeup of our study varies from the national population and possible reasons could include either a higher incidence of ALS in Whites, undiagnosed or unreported cases of ALS in the minority populations, or improper collection of medical history on death certificates. A recent review of the ethnic variation of incidence in ALS showed lower rates in Africans, Asians, and Hispanics compared to Whites(12). Moreover, in a study of the Cuban population, the overall mortality rate was similar to the United States Hispanic mortality rate and even lower in Blacks and mixed race individuals(13) and an Ecuadorian study showed a reduced incidence of ALS in this South American population compared to the United States(14). However another study of an inner city population in London showed a similar incidence of ALS in patients with a European ancestry compared to an African ancestry suggesting similar incidence rates in these groups, although the confidence intervals are large(15).
In summary, although the preferred place of death for most patients is home, racial/ethnic minorities, men, and unmarried individuals are less likely to achieve this goal. Further studies are recommended to better characterize the sentiments of these populations and to identify whether barriers exist for executing a patient’s preferred end-of-life plan.
Acknowledgements
Dr. Callaghan receives research support from NIH K23 NS079417, the Katherine Rayner Program, and the Taubman Medical Institute. Dr. Burke receives research support from NIH K08 NS082597. Dr. Skolarus receives research support from NIH K23 NS073685.
BCC - Dr. Callaghan reports that he receives research support from Impeto Medical and is a consultant for the ALS Association.
JFB - Dr. Burke is funded by NIH K08 NS082597
Abbreviations
- ACF
acute care facility
- ALS
amyotrophic lateral sclerosis
- aMOR
adjusted multinomial odds ratio
- CDC
The Centers for Disease Control and Prevention
- NH
nursing home
Footnotes
Disclosures:
SAG - Dr. Goutman reports no disclosures
DGN -Dr. Nowacek reports no disclosures
KAK - Dr.Kerber reports no disclosures
LES - Dr. Skolarus reports no disclosures
Contributor Information
Stephen A Goutman, Email: sgoutman@med.umich.edu.
Dustin G Nowacek, Email: nowacekd@gmail.com.
James F Burke, Email: jamesbur@med.umich.edu.
Kevin A Kerber, Email: kakerber@umich.edu.
Lesli E Skolarus, Email: lerusche@med.umich.edu.
Brian C Callaghan, Email: bcallagh@med.umich.edu.
References
- 1.Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, et al. Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2013 Dec 10;81(24):2136–2140. doi: 10.1212/01.wnl.0000437305.37850.f9. PubMed PMID: 24271651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000 Nov 15;284(19):2476–2482. doi: 10.1001/jama.284.19.2476. PubMed PMID: 11074777. [DOI] [PubMed] [Google Scholar]
- 3.Gruneir A, Mor V, Weitzen S, Truchil R, Teno J, Roy J. Where people die: a multilevel approach to understanding influences on site of death in America. Med Care Res Rev. 2007 Aug;64(4):351–378. doi: 10.1177/1077558707301810. PubMed PMID: 17684107. Epub 2007/08/09. eng. [DOI] [PubMed] [Google Scholar]
- 4.Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol. 2010 Oct 10;28(29):4457–4464. doi: 10.1200/JCO.2009.26.3863. PubMed PMID: 20837950. Pubmed Central PMCID: 2988637. Epub 2010/09/15. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004 Jan 7;291(1):88–93. doi: 10.1001/jama.291.1.88. PubMed PMID: 14709580. Epub 2004/01/08. eng. [DOI] [PubMed] [Google Scholar]
- 6.Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000 Fall;3(3):287–300. doi: 10.1089/jpm.2000.3.287. PubMed PMID: 15859670. [DOI] [PubMed] [Google Scholar]
- 7.Gallagher R, Krawczyk M. Family members' perceptions of end-of-life care across diverse locations of care. BMC palliative care. 2013;12(1):25. doi: 10.1186/1472-684X-12-25. PubMed PMID: 23870101. Pubmed Central PMCID: 3750390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Mandler RN, Anderson FA, Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M. The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203–208. doi: 10.1080/14660820152882214. PubMed PMID: 11958732. Epub 2002/04/18. eng. [DOI] [PubMed] [Google Scholar]
- 9.Johnson KS, Kuchibhatla M, Tulsky JA. What explains racial differences in the use of advance directives and attitudes toward hospice care? J Am Geriatr Soc. 2008 Oct;56(10):1953–1958. doi: 10.1111/j.1532-5415.2008.01919.x. PubMed PMID: 18771455. Pubmed Central PMCID: 2631440. Epub 2008/09/06. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gomes B, Higginson IJ. Factors influencing death at home in terminally ill patients with cancer: systematic review. Bmj. 2006 Mar 4;332(7540):515–521. doi: 10.1136/bmj.38740.614954.55. PubMed PMID: 16467346. Pubmed Central PMCID: 1388126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.2010 Census Data. [cited 2014 March 27, 2014]; Available from: http://www.census.gov/2010census/data/.
- 12.Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007 Mar 27;68(13):1002–1007. doi: 10.1212/01.wnl.0000258551.96893.6f. PubMed PMID: 17389304. [DOI] [PubMed] [Google Scholar]
- 13.Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009 May 12;72(19):1640–1645. doi: 10.1212/WNL.0b013e3181a55f7b. PubMed PMID: 19433736. [DOI] [PubMed] [Google Scholar]
- 14.Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1–2):106–113. doi: 10.3109/21678421.2013.852590. PubMed PMID: 24245684. [DOI] [PubMed] [Google Scholar]
- 15.Rojas-Garcia R, Scott KM, Roche JC, Scotton W, Martin N, Janssen A, et al. No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London. Amyotroph Lateral Scler. 2012 Jan;13(1):66–68. doi: 10.3109/17482968.2011.636049. PubMed PMID: 22214355. [DOI] [PubMed] [Google Scholar]
